Less Ads, More Data, More Tools Register for FREE

TyraTech Shares Jump As 34% Shareholder Agrees To Buy Rest

Fri, 28th Sep 2018 11:42

LONDON (Alliance News) - Shares rose in TyraTech Inc on Friday as it reported a rise in revenue for the first half of 2018, and accepted an agreement by American Vanguard Corp to acquire all TyraTech shares it does not already own.

Shares in the life sciences company rose 32% at 2.97 pence on Friday.

For the six months to the end of June, TyraTech's pretax loss widened to USD1.9 million from USD1.7 million, due to the lack of a gain on the sale of an intellectual property made the prior year.

This was in spite of a rise in gross revenue to GBP843,000 from GBP490,000, the increase coming from the transaction services agreement following the sale of the head-lice Vamousse brand in December for USD17.5 million to Alliance Pharma PLC.

In addition, TyraTech said it signed an agreement with 34% shareholder American Vanguard Corp for American Vanguard to acquire the remaining stock it does not already own for 3.15 pence per share.

The price reflects a 54% premium over the TyraTech's Wednesday closing price at 2.05 pence.

The merger agreement is conditional on gaining at least 75% of shareholder approval at a general meeting on October 26. TyraTech has recommended that shareholders approve the deal, otherwise it said the company's financial situation is "not sustainable".

Should the merger be approved, it is expected to be completed in November 6, resulting in TyraTech's shares being cancelled from AIM.

"In December 2017 when writing to shareholders concerning the disposal of Vamousse and the return of capital to TyraTech shareholders, we explained that we believed that the company's animal health business was capable of being developed to serve much larger markets than its initial products, but that this would require additional funding. However, this funding has not been forthcoming. Accordingly, we have decided to enter into the conditional Merger Agreement with AMVAC," said Chairman Jose Barella.

"The independent directors believe TyraTech's shareholders, employees and business will be better positioned following the company's acquisition by AMVAC than if TyraTech had remained as an independent entity," Barella added.

Related Shares

More News

TyraTech enters into merger agreement with American Vanguard Corporation

(Sharecast News) - Life sciences company TyraTech has entered into a conditional merger agreement with American Vanguard Corporation, whereby, conditional upon approval by TyraTech shareholders, AMVAC would acquire the remaining shares of common stock in TyraTech which it did not already own, for a consideration of 3.15p per share, it announced on Friday.

28 Sep 18 14:53

TyraTech Shares Jump As 34% Shareholder Agrees To Buy Rest

LONDON (Alliance News) - Shares rose in TyraTech Inc on Friday as it reported a rise in revenue for the first half of 2018, and accepted an agreement by American Vanguard Corp to acquire all it in

28 Sep 18 11:42

TyraTech 2017 Revenue Grows With New Focus On Animal Health

LONDON (Alliance News) - Life sciences company TyraTech Inc on Wednesday reported a narrowed loss for 2017 as revenue nearly doubled due to substantial growth in its product division.For a

23 May 18 12:58

TyraTech Making Progress On All Operational Goals For 2019

LONDON (Alliance News) - Pest control company TyraTech Inc on Wednesday reported progress on all 2018 operational goals including products controlling parasites in production animals.The on

9 May 18 13:52

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.